J.E. Karp
University of Maryland Greenebaum Cancer Center
22 S Greene St.
Baltimore
MD 21201
USA
Name/email consistency: high
- Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial. Karp, J.E., Lancet, J.E., Kaufmann, S.H., End, D.W., Wright, J.J., Bol, K., Horak, I., Tidwell, M.L., Liesveld, J., Kottke, T.J., Ange, D., Buddharaju, L., Gojo, I., Highsmith, W.E., Belly, R.T., Hohl, R.J., Rybak, M.E., Thibault, A., Rosenblatt, J. Blood (2001)
- Current status of clinical trials of farnesyltransferase inhibitors. Karp, J.E., Kaufmann, S.H., Adjei, A.A., Lancet, J.E., Wright, J.J., End, D.W. Curr. Opin. Oncol (2001)